Your browser doesn't support javascript.
loading
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
Strosberg, Jonathan; Kunz, Pamela L; Hendifar, Andrew; Yao, James; Bushnell, David; Kulke, Matthew H; Baum, Richard P; Caplin, Martyn; Ruszniewski, Philippe; Delpassand, Ebrahim; Hobday, Timothy; Verslype, Chris; Benson, Al; Srirajaskanthan, Rajaventhan; Pavel, Marianne; Mora, Jaume; Berlin, Jordan; Grande, Enrique; Reed, Nicholas; Seregni, Ettore; Paganelli, Giovanni; Severi, Stefano; Morse, Michael; Metz, David C; Ansquer, Catherine; Courbon, Frédéric; Al-Nahhas, Adil; Baudin, Eric; Giammarile, Francesco; Taïeb, David; Mittra, Erik; Wolin, Edward; O'Dorisio, Thomas M; Lebtahi, Rachida; Deroose, Christophe M; Grana, Chiara M; Bodei, Lisa; Öberg, Kjell; Polack, Berna Degirmenci; He, Beilei; Mariani, Maurizio F; Gericke, Germo; Santoro, Paola; Erion, Jack L; Ravasi, Laura; Krenning, Eric.
Afiliación
  • Strosberg J; Gastrointestinal Department/Neuroendocrine Tumor Division, Moffitt Cancer Center, Tampa, FL, USA. jonathan.strosberg@moffitt.org.
  • Kunz PL; Department of Medicine - Med/Oncology, Stanford University Medical Center, Stanford, CA, USA.
  • Hendifar A; Department of Internal Medicine/Hematology/Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Yao J; Department of Gastrointestinal Medicinal Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bushnell D; Department of Radiology, The University of Iowa, Iowa City, IA, USA.
  • Kulke MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Baum RP; Department of Nuclear Medicine, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Caplin M; Department of Gastroenterology and Tumour Neuroendocrinology, Royal Free Hospital, London, UK.
  • Ruszniewski P; Division of Gastroenterology and Pancreatology, Hôpital Beaujon, Clichy, France.
  • Delpassand E; Department of Clinical Nuclear Medicine, Excel Diagnostics Imaging Clinic, Houston, TX, USA.
  • Hobday T; Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Verslype C; Department of Hepatology, University Hospitals and KU Leuven, Leuven, Belgium.
  • Benson A; Hematology Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
  • Srirajaskanthan R; Department of Gastroenterology and General Internal Medicine, King's College Hospital - NHS Foundation Trust, London, UK.
  • Pavel M; Division of Hepatology and Gastroenterology, Charite-Universitätsmedizin Berlin, Berlin, Germany.
  • Mora J; Department of Nuclear Medicine, Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Berlin J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
  • Reed N; Department of Medical Oncology, Beatson Oncology Centre, Glasgow, UK.
  • Seregni E; Department of Nuclear Medicine Therapy and Endocrinology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.
  • Paganelli G; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Severi S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Morse M; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Metz DC; GI Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Ansquer C; Nuclear Medicine Department, Hôtel Dieu, University Hospital, Nantes, France.
  • Courbon F; Medical Imaging, Oncology University Institut Claudius Regaud, Toulouse, France.
  • Al-Nahhas A; Division of Imaging and Interventional Radiology, Imperial College London, London, UK.
  • Baudin E; Department of Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy, Villejuif, France.
  • Giammarile F; Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
  • Taïeb D; Department of Nuclear Medicine, Hôpital de la Timone, Marseille, France.
  • Mittra E; Department of Nuclear Medicine, Oregon Health & Science University, Portland, OR, USA.
  • Wolin E; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • O'Dorisio TM; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA.
  • Lebtahi R; Department of Nuclear Medicine, Royal Free Hospital, London, UK.
  • Deroose CM; Nuclear Medicine Department, University Hospitals and KU Leuven, Leuven, Belgium.
  • Grana CM; Division of Nuclear Medicine, Istituto Europeo di Oncologia, Milan, Italy.
  • Bodei L; Department of Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Öberg K; Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.
  • Polack BD; Department of Medical Information, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
  • He B; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
  • Mariani MF; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
  • Gericke G; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
  • Santoro P; Department of Clinical Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
  • Erion JL; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
  • Ravasi L; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
  • Krenning E; Department of Nuclear Medicine, Cyclotron Rotterdam BV, Erasmus University Medical Center, Rotterdam, Netherlands.
Eur J Nucl Med Mol Imaging ; 47(10): 2372-2382, 2020 09.
Article en En | MEDLINE | ID: mdl-32123969
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Tumores Neuroendocrinos / Neoplasias Hepáticas Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Tumores Neuroendocrinos / Neoplasias Hepáticas Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania